ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
| Business Activity | PASS |
| Debt Ratio (0.10%) | PASS |
| Cash Ratio (0.00%) | PASS |
| Receivables Ratio (0.26%) | PASS |
| Revenue Ratio (0.00%) | PASS |
| Overall | PASS |
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-08-06 | 2.90 | Pending | -- |
| 2026-04-30 | 2.80 | 2.86 | +2.1% |
| 2026-01-29 | 2.72 | 2.81 | +3.1% |
| 2025-10-30 | 2.50 | 2.55 | +2.0% |
| 2025-07-31 | 2.48 | 2.55 | +2.8% |
| 2025-04-23 | 2.36 | 2.37 | +0.4% |
| 2025-01-30 | 2.31 | 2.43 | +5.0% |
| 2024-10-24 | 2.04 | 2.20 | +7.7% |
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1.4B | $398.7M | $568.8M | $891.0M | $499.8M | 2.74 |
| 2025-12-31 | $1.4B | $392.6M | $559.9M | $878.7M | $497.6M | 2.69 |
| 2025-09-30 | $1.3B | $348.5M | $520.0M | $820.8M | $462.3M | 2.38 |
| 2025-06-30 | $1.3B | $379.7M | $530.9M | $820.1M | $456.6M | 2.59 |
| 2025-03-31 | $1.3B | $365.0M | $478.2M | $766.4M | $426.3M | 2.49 |
| 2024-12-31 | — | — | — | — | — | — |
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-05-07 | FARRELL MICHAEL J | Chief Executive Officer | 4,991 | $730.4K |
| 2026-05-07 | FARRELL MICHAEL J | Chief Executive Officer | 4,991 | $1.0M |
| 2026-04-07 | FARRELL MICHAEL J | Chief Executive Officer | 4,991 | $730.4K |
| 2026-04-07 | FARRELL MICHAEL J | Chief Executive Officer | 4,991 | $1.1M |
| 2026-04-01 | FARRELL PETER CRAIG | Director | 2,000 | $450.0K |
| 2026-04-01 | SANDERCOCK BRETT | Chief Financial Officer | 1,000 | $224.3K |
| 2026-03-09 | FARRELL MICHAEL J | Chief Executive Officer | 4,991 | $730.4K |
| 2026-03-09 | FARRELL MICHAEL J | Chief Executive Officer | 4,991 | $1.3M |
| 2026-03-04 | FARRELL PETER CRAIG | Director | 2,000 | $520.4K |
| 2026-03-02 | SANDERCOCK BRETT | Chief Financial Officer | 1,000 | $254.3K |
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Blackrock Inc. | 12.1M | $2.5B | 0.1% |
| Vanguard Capital Management LLC | 9.5M | $2.0B | 0.1% |
| Vanguard Portfolio Management LLC | 7.9M | $1.6B | 0.1% |
| State Street Corporation | 6.6M | $1.4B | 0.0% |
| Bank Of New York Mellon Corporation | 4.9M | $1.0B | 0.0% |
| Geode Capital Management, LLC | 4.4M | $905.6M | 0.0% |
| Morgan Stanley | 2.7M | $559.0M | 0.0% |
| Invesco Ltd. | 2.0M | $407.1M | 0.0% |
| Northern Trust Corporation | 1.7M | $359.0M | 0.0% |
| First Trust Advisors LP | 1.5M | $319.9M | 0.0% |
$29.4B
4.79
0.845
15
$5.5B
$843.2M
+10.5%
1.2%
2.11
11.67
0.1%
10,600
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2026-08-06 | $2.90 | Pending | — |
| 2026-04-30 | $2.80 | $2.86 | +2.1% |
| 2026-01-29 | $2.72 | $2.81 | +3.1% |
| 2025-10-30 | $2.50 | $2.55 | +2.0% |
| 2025-07-31 | $2.48 | $2.55 | +2.8% |
| 2025-04-23 | $2.36 | $2.37 | +0.4% |
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($270.60, 15 analysts) | |||
| 10 | $2,026.60 | +$679.40 (34%) | 2.2R |
| 50 | $10,133.00 | +$3,397.00 (34%) | 2.2R |
| 100 | $20,266.00 | +$6,794.00 (34%) | 2.2R |
| To Fair Value ($145.85) | |||
| 10 | $2,026.60 | +$-568.10 (-28%) | -1.9R |
| 50 | $10,133.00 | +$-2,840.50 (-28%) | -1.9R |
| 100 | $20,266.00 | +$-5,681.00 (-28%) | -1.9R |
- Elevated short interest (11.67 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| ADJEX | 0.415 |
| GEHC | 0.413 |
| IDXX | 0.403 |
| XLV | 0.395 |
| SOLV | 0.392 |
| Ticker | Correlation |
|---|---|
| SEEF.BH | -0.174 |
| SUKOON.AE | -0.172 |
| NTBLQ | -0.147 |
| 6841.T | -0.144 |
| ALSALAMSUDAN.AE | -0.138 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.